antibioticsbooks

302 Index
HIV (continued)
anti-herpes simplex virus
agents and, 208
azithromycin and, 20
entry and fusion inhibitors
and, 239, 240
folate antagonists and, 134
integrase inhibitors and,
235–237
nucleoside reverse
transcriptase inhibitors
(NRTIs) and, 221–224
non-nucleoside reverse
transcriptase inhibitors
(NNRTIs) and, 228
protease inhibitors, 229–230,
232, 245–246, 247
rifamycins and, 154
Hives, 41, 70
HMG-CoA reductase inhibitors, 131
Hookworms, 269
Hospital-acquired pneumonia,
20, 84
HSV. See Herpes simplex virus
(HSV)
Hydrochlorothiazide, 136
Hydrocortisone, 172, 173
Hydroxychloroquine, described,
261–264
Hyperbilirubinemia, 79
Hyperglycemia, 274
Hyperinfection syndrome,
Strongyloides, 277
Hyperkalemia, 134
Hyperlipidemia, 223, 227
Hypersensitivity, 154, 158, 222,
226–227
Hypertension, 21
Hyperuricemia, 161–162
Hypocalcemia, 274
Hypoglycemia, 262, 274
Hypoinsulinemia, 274
Hypokalemia, 274
Hypotension, 262, 273–274, 278
I
Ideal body weight, 28
Imipenem
cilastatin, 20–21
described, 87–89
Immunosuppressive therapy, 16
Indinavir (IDV), described,
229–233
Induction of enzymes, 30
Infectious diseases, general
approach to
case study, 21–22
definitive therapy, 18, 20–21
empiric therapy, 17–18, 20
prophylactic therapy, 16–17,
19–20
rapid diagnostics, 22
Influenza, 7, 203, 215–217, 249
Inhibition of enzymes, 30
Insomnia, 98, 226, 250, 262
Insulin, 223, 262, 274, 275
Integrase strand transfer inhibitors
(INSTI), 235–237
Interferon-a 2a, described,
241–244
Interferon-b 2b, described,
241–244
Interferons, 245–247,
249–250
described, 241–244
Intestinal nematode infections,
270
Intestinal worm infections,
269, 270
Intra-abdominal infections, 68,
89, 139
Iron, 26
Isoniazid, 26, 155, 164
described, 157–159
Itraconazole, 26, 179, 189, 193
described, 185–187
Ivermectin, 258
described, 277–279
J
Jaundice, 226
K
Kaletra, 229, 230
Ketoconazole, 179
Ketolides, described, 109–112
Kingella, 13
Klebsiella, 12, 14, 97, 122
aminoglycosides and, 102
K. pneumoniae, 20, 142